Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–18 of 18 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03866382
- Conditions
- Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT04981509
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
NCT07024680
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Not Yet Recruiting
Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy
NCT06146777
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
Not specified
NCT06339138
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT00898365
- Conditions
- Adenocarcinoma, Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, +46 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
NCT01767636
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma of the Collecting Ducts of Bellini, +23 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT02489695
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- ICO Paul Papin Angers, France
- Chu Bordeaux Bordeaux, France
- Centre Francois Baclesse Caen, France
- Centre Geogres François Leclerc Dijon, France
NCT00335556
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +31 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of South Alabama Mobile, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
NCT00126503
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC
NCT04413123
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Brigham & Woman's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- UT Southwestern Medical Dallas, Texas, United States
Active, Not Recruiting
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
NCT03541902
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson Regional Care Center-Katy Houston, Texas, United States
- MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
Active, Not Recruiting
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT04071223
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Rush MD Anderson Cancer Center Chicago, Illinois, United States
Active, Not Recruiting
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
NCT05043090
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- Research Site Boston, Massachusetts, United States
- Research Site New York, United States
- Research Site CABA, Argentina
- Research Site Ciudad Autónoma Buenos Aires, Argentina
Active, Not Recruiting
A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
NCT03635892
- Conditions
- Adenocarcinoma, Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Carcinoma, +20 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, Not Recruiting
Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer
NCT05620134
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +86 more
- Locations
-
- Institut Jules Bordet Brussels, Belgium
- UZA Edegem, Belgium
- UZ Ghent Ghent, Belgium
- CHU UCL Namur - site Godinne Yvoir, Belgium